Related Experiment Video
Updated: Jan 27, 2026

Creation of Two Saccular Elastase-Digested Aneurysms with Different Hemodynamics in One Rabbit
Published on: April 15, 2021
Morphometry and hemodynamics of coronary artery aneurysms caused by atherosclerosis
Tingting Fan1, Zhen Zhou2, Wenxuan Fang1
1Department of Mechanics and Engineering Science, College of Engineering, Peking University, Beijing, China; PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China.
Insights
Coronary artery aneurysms (CAAs) are linked to atherosclerosis. A new two-step analysis identifies coronary artery bifurcations and aneurysm shape as key risk factors for CAA development and associated ischemia.
Area of Science:
- Cardiovascular research
- Medical imaging analysis
- Biomechanical engineering
Background:
- Atherosclerosis is the primary cause of coronary artery aneurysms (CAAs), posing challenges in preventing their development.
- Understanding the morphometric and hemodynamic factors contributing to CAA is crucial for risk assessment.
Purpose of the Study:
- To conduct morphometric and hemodynamic analyses of epicardial coronary arteries in patients with atherosclerosis-induced CAAs.
- To develop and validate a novel two-step analysis method for enhanced CAA risk stratification.
Main Methods:
- Reconstruction of epicardial coronary arterial trees from 61 patients.
- Determination of morphometric and hemodynamic parameters using computed flow fields.
- Implementation of a two-step analysis prioritizing coronary artery bifurcation and aneurysm shape index (L/W).
Main Results:
- Coronary artery bifurcations are identified as a major risk factor for CAA, followed by a high aneurysm shape index (L/W).
- Patients with CAAs covering bifurcations exhibit a higher incidence of myocardial ischemia (71% vs. 43% for L/W ≥ 2) compared to those with CAAs in single vessels.
- CAAs with L/W ≥ 2 at bifurcations present the most adverse hemodynamic environment.
Conclusions:
- Morphometric and hemodynamic findings support the proposed two-step analysis method for CAA risk assessment.
- This approach offers a clinical rationale for noninvasive evaluation of coronary artery aneurysms.
Background And Aims:
Atherosclerosis is the first etiology of coronary artery aneurysm (CAA). It is, however, challenging to inhibit the development of CAA. The aim of the study is to carry out morphometric and hemodynamic analyses in epicardial coronary arteries of patients with CAAs caused by atherosclerosis.
Methods:
Various morphometric parameters were obtained from the reconstructed epicardial coronary arterial trees of 61 patients and multiple hemodynamic parameters were determined from the computed flow fields. A two-step analysis method was proposed to enhance the risk assessment of CAAs, i.e., coronary artery bifurcation is the major risk factor for CAA followed by high aneurysm shape index (L/W, where L and W refer to the aneurysm length and maximum diameter, respectively).
Results:
Patients with CAA covering a bifurcation have the higher occurrence (71% and 55% for L/W ≥ 2 and L/W < 2, respectively) of myocardial ischemia relevant to abnormal hemodynamic parameters in comparison with those with CAA in one vessel (43% and 40% for L/W ≥ 2 and L/W < 2, respectively). Patients with CAA of L/W ≥ 2 covering a bifurcation show the worst hemodynamic environment.
Conclusions:
Morphometric and hemodynamic studies support the two-step analysis method, which provides a clinical rationale for the noninvasive assessment of CAAs.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis III: Management